디지털 병리학 시장은 2023-2030년간 8.7%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 18억 6,000만 달러에 달할 것으로 예측됩니다.
이 보고서는 광범위한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 시장 성장 촉진요인 및 과제에 대한 분석을 제공합니다.
이 시장의 성장은 만성 질환의 유병률 증가, 실험실의 효율성을 높이기 위한 디지털 병리 솔루션의 채택 증가, 동반 진단 및 의약품 개발에서 디지털 병리 진단의 적용 확대에 기인합니다. 그러나 디지털 병리 검사 서비스에 대한 상환이 없습니다는 점이 이 시장의 성장을 저해하는 요인으로 작용하고 있습니다.
또한, 개인 맞춤형 의료에 대한 수요 증가, 민간 병리 클리닉을 위한 저렴한 가격의 스캐너 출시, 신흥 경제 국가들은 디지털 병리 솔루션 제공업체들에게 큰 비즈니스 기회를 창출하고 있습니다. 그러나 디지털 병리학에 대한 법적 규제 장벽과 숙련된 병리학자 부족은 이 시장에서 큰 도전 과제입니다.
Digital Pathology Market Size, Share, Forecast, & Trends Analysis by Offering (Hardware [Scanner, Tissue Microarray], Software [Information Management, Image Analysis], Service), Application (Diagnostic, Drug Discovery), End User-Global Forecast to 2030
The digital pathology market is projected to reach $1.86 billion by 2030 at a CAGR of 8.7% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the rising prevalence of chronic diseases, the increasing adoption of digital pathology solutions to enhance lab efficiency, and the widening applications of digital pathology in companion diagnostics and drug development. However, the lack of reimbursements for digital pathology services restrains the growth of this market.
Furthermore, the rising demand for personalized medicine, the launch of affordable scanners for private pathology practices, and developing economies are generating significant opportunities for digital pathology solutions providers. However, the legal and regulatory hurdles in digital pathology and the shortage of trained pathologists are major challenges in this market.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the digital pathology market are 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.).
Based on offering, in 2023, the hardware segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased demand for precise & accurate diagnosis and an increase in patients requiring in vitro tests.
Based on application, in 2023, the disease diagnosis segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and rising awareness about the importance of early disease diagnosis.
Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased availability and affordability of advanced technological pathology solutions at hospitals, the higher preference for hospitals/clinics as a primary center for care, and the high volume of patient inflow in hospitals & clinics.
An in-depth analysis of the geographical scenario in the digital pathology market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the digital pathology market. Furthermore, in 2023, the U.S. is expected to hold the major market share in North America. Market growth in the U.S. is driven by the digitization of pathology services, high investments in R&D, the high adoption of advanced technologies, and the increased demand for reliable and faster diagnostics.
Digital Pathology Market Assessment-by Offering
Note 1: Other hardware includes clinical microscopes and accessories.
Note 2: Other software includes digital storage systems, tissue microarray software, and telepathology platforms.
Digital Pathology Market Assessment-by Application
Digital Pathology Market Assessment-by End User
Digital Pathology Market Assessment-by Geography